These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2865117)

  • 1. An analysis of naltrexone and naloxone's possible agonistic actions in the dog.
    Wettstein JG; Martin WR
    Drug Alcohol Depend; 1985 Aug; 15(4):353-60. PubMed ID: 2865117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary kappa hyperalgesic mechanisms II. The effects of ethylketazocine administered into the fourth cerebral ventricle of the conscious dog.
    Kamerling SG; Martin WR; Wu KM; Wettstein JG
    Life Sci; 1983 Oct; 33(18):1839-43. PubMed ID: 6139723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcotic discrimination in pigeons: antagonism by naltrexone.
    Herling S; Valentino RJ; Solomon RE; Woods JH
    Eur J Pharmacol; 1984 Oct; 105(1-2):137-42. PubMed ID: 6386494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ethylketazocine and morphine alone and in combination with naloxone on schedule-controlled behavior in pigeons.
    Katz JL
    Psychopharmacology (Berl); 1987; 92(4):508-12. PubMed ID: 2888154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible medullary kappa hyperalgesic mechanism. I. A new potential role for endogenous opioid peptides in pain perception.
    Wu KM; Martin WR; Kamerling SG; Wettstein JG
    Life Sci; 1983 Oct; 33(18):1831-8. PubMed ID: 6139722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEG and behavioral effects of ethylketocyclazocine, morphine and cyclazocine in rats: differential sensitivities towards naloxone.
    Tortella FC; Cowan A; Adler MW
    Neuropharmacology; 1980 Sep; 19(9):845-50. PubMed ID: 6106909
    [No Abstract]   [Full Text] [Related]  

  • 8. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine.
    Wood PL; Rackham A; Richard J
    Life Sci; 1981 May; 28(19):2119-25. PubMed ID: 6114371
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice.
    Ward SJ; Takemori AE
    Life Sci; 1982 Sep 20-27; 31(12-13):1267-70. PubMed ID: 6128653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
    Harris RA
    J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone.
    Paronis CA; Holtzman SG
    Life Sci; 1992; 50(19):1407-16. PubMed ID: 1573974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine.
    Hynes MD; Hymson DL
    Eur J Pharmacol; 1984 Oct; 105(1-2):155-9. PubMed ID: 6149142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat.
    Sharpe LG
    J Pharmacol Exp Ther; 1991 Mar; 256(3):845-9. PubMed ID: 1672378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
    Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog.
    Wu KM; Martin WR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):302-7. PubMed ID: 6313895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: antagonism by naloxone.
    Leander JD
    Neuropharmacology; 1982 Sep; 21(9):923-8. PubMed ID: 6128693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action.
    Herling S; Hein DW; Nemeth MA; Valentino RJ; Woods JH
    Life Sci; 1982 Jan; 30(4):331-41. PubMed ID: 6122153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.